AURA · Aura Biosciences Inc
United States · RS rating 31 · As of 2026-10-14
| Price | 6.17 USD |
|---|---|
| 1-day change | -1.6% |
| RS rating (overall / 1M / 3M / 12M) | 31 / 22 / 31 / 46 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 21 / 23 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +4.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +30.7% |
| Market cap (USD) | $466.1M |